Jillanne Schulte Wall
With the Nov. 27, 2024, deadline for the Drug Supply Chain Security Act (DSCSA) less than three months away, many pharmacies and the organizations that represent them are sounding the alarm about lack of readiness from upstream trading partners, particularly at the manufacturer level.
When it was initially passed in 2013 with the goal of creating a single, consistent federal traceability framework for prescription medications, the DSCSA laid out a 10-year time